INTRODUCTION
Periodicity of eukaryotic cell-cycle events is driven by oscillations of cyclin-dependent kinase (Cdk) activity (Morgan, 2007) . Checkpoint surveillance mechanisms enforce correct ordering of events by delaying subsequent events until previous ones are finished; however, checkpoints are not generally essential for ordering the unperturbed cell cycle (Elledge, 1996; Weinert et al., 1994) .
Cdk activity oscillation can order cell-cycle events by a ''ratchet''-like mechanism: high cyclin-Cdk activity triggers the initiation of a cell-cycle event, but inhibits its completion or reinitiation (Nasmyth, 1996; Stern and Nurse, 1996) . Therefore, as a result of having different thresholds for cyclin-Cdk, cell-cycle events occur in order, exactly once per cyclin-Cdk cycle. This mechanism is well established in control of DNA replication (Kearsey and Cotterill, 2003) , and similar ratchet-like mechanisms may apply to processes such as spindle and bud morphogenesis (Bloom and Cross, 2007) .
Independent of molecular mechanisms, ratchet control entails that locking Cdk activity at any constant level should arrest the controlled process at a specific step. However, some cellcycle events may occur cyclically without oscillation of mitotic cyclin-Cdk activity, such as SPB/centrosome duplication cycles, and periodic budding and cell-cycle-regulated transcription in budding yeast (Gard et al., 1990; Haase and Reed, 1999; Haase et al., 2001; McCleland and O'Farrell, 2008; Sluder et al., 1990) . Such ''endocycles'' pose a challenge to the concept of cyclinCdk-based ratchet control, but the relevance of these endocycles to the mitotic cell cycle, and what mechanism, if any, entrains them to mitotic cyclin-Cdk cycles, remains unclear.
Cdc14 is an essential mitotic phosphatase in budding yeast. Cdc14 is restrained and inhibited in the nucleolus by the constitutively nucleolar Net1p, except in mitosis (Shou et al., 1999; Visintin et al., 1999) . The spindle orientation checkpoint (SPOC, regulating the mitotic exit network MEN) and cyclin-Cdk oscillation can regulate Cdc14 localization and activity (Azzam et al., 2004; Bardin et al., 2000; Jaspersen and Morgan, 2000; Pereira et al., 2000; Queralt et al., 2006; Stegmeier and Amon, 2004; Stegmeier et al., 2002) . Disrupting SPOC control by removing the Bub2 inhibitor has almost no effect on Cdc14 release in unperturbed cell cycles, suggesting that mitotic cyclin (Clb)-Cdk oscillations may play an important role in regulating Cdc14 release timing. However, it is as yet unclear how Cdc14 localization responses to different Clb levels, and whether these controls constitute a ratchet mechanism sufficient to lock Cdc14 release to once per cell cycle.
To understand whether Clb-Cdk oscillations control Cdc14 localization through a ''ratchet''-like mechanism, we locked mitotic cyclin Clb2 at stable physiological levels, by titrated pulses of undegradable Clb2, and correlated Cdc14 release and mitotic exit (ME) events to Clb2 levels in individual cells, following a recently developed procedure (Drapkin et al., 2009) . High Clb2 blocks ME (Surana et al., 1993 ); however, the peak level of Clb2-Cdk activity attained in a normal cell cycle was inefficient at restraining ME (Drapkin et al., 2009) , posing a problem for the simple cyclin-based ratchet model. Sharpening this contrast, here we show that Cdc14 cycles in and out of the nucleolus multiple times at high but physiological fixed mitotic cyclin levels. These and other results lead us to propose that Cdc14 release, and likely other cell-cycle processes, are controlled by intrinsically oscillatory modules, that are entrained to a single occurrence at appropriate cell-cycle positions by cyclin-Cdk cycles through a ''phase-locking'' mechanism.
RESULTS

Blocking Mitotic Exit with Undegradable Clb2kd Reveals Cdc14 Release Endocycles
We determined the response of the Cdc14 release cycle to fixed cyclin-Cdk levels (Drapkin et al., 2009) , using a quantitative, single cell measurement for Cdc14 localization based on variation of cellular Cdc14-YFP pixel intensities, standardized to variation of nucleolar Net1-mCherry ) (Experimental Procedures; Figure 1A ).
We blocked cells in metaphase by depleting the essential anaphase-promoting complex (APC) activator Cdc20, by shutoff of MET3-CDC20 (Sullivan et al., 2001 ). Cdc20 promotes proteolysis of the anaphase inhibitor Pds1, and initial proteolysis of B-type cyclins (Shirayama et al., 1998; Wä sch and Cross, 2002; Yeong et al., 2000) . We briefly pulsed cdc20-blocked cells with stable mitotic cyclin Clb2kd-GFP lacking destruction and KEN boxes recognized by the APC activators Cdc20 and Cdh1 (Pfleger and Kirschner, 2000; Schwab et al., 1997; Visintin et al., 1998; Wä sch and Cross, 2002) . Stable Clb2kd-GFP accumulates in these cells to a level averaging around the peak Clb2-GFP level in a wild-type cell cycle (13 peak; Figure S1A available online).
Reinducing MET3-CDC20 induced anaphase, which proceeded on schedule independent of stable Clb2kd-GFP (data not shown). Clb2kd-GFP and associated kinase activity was constant through this protocol (Drapkin et al., 2009 ). We assayed post-anaphase events as a function of single-cell Clb2kd-GFP levels ( Figure 1C) .
Greater than or equal to 1X peak Clb2kd-GFP induced dose-dependent delays in cytokinesis and bud emergence ( Figure S1B ) (Drapkin et al., 2009 ). In contrast, Cdc14-YFP was released from the nucleolus and subsequently resequestered, with essentially normal kinetics, up to at least 3X peak Clb2kd-GFP ( Figure 1D ; Drapkin et al., 2009) . Strong overexpression of stable Clb2 was shown previously to cause extended Cdc14 release (Stegmeier et al., 2002) . We confirmed this observation with continuous galactose induction of GAL1-CLB2kd (yielding > = 10-fold peak Clb2kd levels [ Figure S1C ]). However, in the following we pursue only results obtained at approximately physiological Clb2kd levels.
Remarkably, cells containing near-1X peak Clb2kd-GFP frequently exhibited multiple endocycles of Cdc14-YFP release and resequestration, before finally undergoing cytokinesis and rebudding (Figure 1B,D; Movie S1).
Cdc14 endocycles occurred without budding, cytokinesis, or nuclear or nucleolar division. The G1 cyclin CLN2 is expressed at cell cycle Start (Wittenberg et al., 1990) . We observed no significant CLN2pr-GFP expression (Bean et al., 2006; Mateus and Avery, 2000) in cells undergoing Cdc14 endocycles, while a burst of CLN2pr expression occurred when these cells finally budded ( Figure 1E ).
In yeast, cyclin-Cdk phosphorylation excludes the MCM helicase complex from the nucleus except in M/G1, helping to restrict prereplicative complex formation to pre-S phase (Kearsey and Cotterill, 2003) . $1X peak Clb2kd-YFP was sufficient to completely block Mcm2-GFP nuclear reaccumulation (Drapkin et al., 2009) , confirming continuous high Clb2kd-associated kinase in this protocol. Consistent with this observation, we observed little or no DNA endoreduplication during Cdc14 endocycles by DNA flow cytometry ( Figure S1D ).
Endogenous Clb2-GFP was uniformly degraded after initial Cdc14 release, regardless of exogenously pulsed Clb2kd levels. (A and B) MET3-CDC20 CDC14-YFP NET1-mCherry MYO1-GFP cells were released from a MET3-CDC20 block (t = 0). Bottom: Cdc14 release was quantified at each time point as the following: the coefficient of variation (CV) of Cdc14-YFP signal inside a single cell, computed from fluorescent time-lapse microscopy data, is the standard deviation of YFP pixel intensity across the cell, divided by the mean intensity; CV of Cdc14-YFP is then divided by CV of Net1-mCherry, and this ratio will be high in cells with Cdc14-YFP concentrated in specific regions, and low when Cdc14-YFP is dispersed through the cell. Triangle, disappearing Myo1 ring. The scale bar represents 5 microns. (A) control. (B) Clb2kd was pulsed for 30 min before release. (C) Schematic of procedure for loading cells with undegradable Clb2kd (green) before ME. Nucleus is shown in blue, spindle in red. (D) Pulsed Clb2kd-GFP was quantified (right column) in units standardized to the peak level of Clb2 attained in a normal cell cycle, and Cdc14 localization quantified (n = 170). Blue bars, anaphase (nucleolar separation, marked by Net1-mCherry); red bars, cytokinesis (Myo1 ring disappearance); green bars, bud emergence. (E) CLN2 promoter expression during Cdc14 endocycles. A CLN2pr-GFP-PEST strain was pulsed with Clb2kd as in (B) for 35 min. GFP intensities at the first Cdc14 release, maximum during endocycles (n = 40), and at rebudding in unpulsed control cells (p < 10 À15) . Error bars represent the standard deviation. See also Figure S1 and Movie S1.
Endogenous Clb2-GFP remained low during Cdc14 endocycles, only reaccumulating upon cessation of endocycles ( Figure S1E ). Cdc14 endocycles are not driven by oscillations of Sic1, the stoichiometric Clb-Cdk inhibitor (Mendenhall and Hodge, 1998) , because Sic1 levels in Clb2kd-pulsed cells were insufficient for Clb2kd inhibition (Drapkin et al., 2009) . Consistently, Cdc14 endocycles were independent of Swi5, the major SIC1 transcription factor (Toyn et al., 1997;  Figure S3A ).
Thus, Cdc14 release endocycles are not due to oscillations of Clb2kd-Cdk or of endogenous G1 or mitotic cyclins. Cdc14 endocycles occur in the absence of cytokinesis, rebudding, Mcm complex nuclear reaccumulation and DNA replication.
Frequency Control of the Cdc14 Release Endocycle by Clb2kd Levels Clb2kd-GFP at less than $0.5X peak had little effect on cellcycle progression (Drapkin et al., 2009) , and a single normal cycle of Cdc14 release and resequestration followed anaphase (marked by nucleolar Net1 separation) ( Figure 2A , category 1). Cdc14 release in the next cell cycle was frequently delayed, possibly due to 2 nd -cycle defects caused by low Clb2kd (Drapkin et al., 2009) . At $0.75X peak levels of Clb2kd-GFP, ME was delayed but not blocked (Drapkin et al., 2009) , and a 2 nd Cdc14-release event sometimes occurred rapidly after Figure S2B ). Shaded, range of cell-cycle frequencies for cycling MET3-CDC20 mother cells. 31/170 category 1; 45/170 category 2; 94/170 category 3. See also Figure S2 .
bud emergence, without associated anaphase ( Figure 1D and Figure 2A ; category 2). At > = 1X peak Clb2kd concentrations, we observed Cdc14 endocycles: repeated Cdc14 release and sequestration without evident cell-cycle progression ( Figure 2A , category 3). Category 2 cells are intermediate between normal, tight linkage of Cdc14 release to cellcycle progression and complete uncoupling as in category 3 endocycling cells, suggesting a continuous transition from normal Cdc14 release cycles to endocycles with increasing Clb2kd.
Below $1.7X peak Clb2kd, Cdc14 release frequency correlated positively with Clb2kd-GFP level ( Figure 2B ; p < 2*10 À7 ) using only data from ''category 3'' cells that undergo endocycles without apparent cell-cycle progression. A quantitatively similar, highly significant positive correlation was observed using all three categories of cells, suggesting that Clb2 levels may directly control Cdc14 release frequency, independent of cell-cycle progression. At Clb2kd > 1.7X peak, endocycle frequency saturated at once per $45 min. Despite considerable noise in the data, we estimated the slope of the Clb2kd/endocycle frequency relationship ( Figure 2B legend) with a linear function (k = 0.013 ± 0.004/ Peak Clb2 À1 min À1 ).
Although Clb2kd levels controlled Cdc14 release frequency, the amplitude and duration of release was independent of Clb2kd ( Figure S2A ). Those observations are important for the theoretical analysis below.
Requirements for Cdc14 Endocycles
A B-type cyclin-independent oscillator may drive G1 events (Haase and Reed, 1999; Orlando et al., 2008) . To determine if this oscillator might also drive Cdc14 endocycles, we overexpressed the stable Clb-Cdk inhibitor Sic1-4A to inhibit all B-type cyclin-Cdk activity (Verma et al., 1997) . Cdc14 remained nucleolar, despite multiple budding without cell division (manifesting the G1 oscillator [Haase and Reed, 1999] ; Figure S3E ).
Additionally, we constructed a cdc14-1 temperature-sensitive strain with all B-cyclins deleted. We collected small G1 cells by elutriation, and incubated them at non-permissive temperature for cdc14-1. cdc14-1 and CDC14 B-cyclin-depleted cells budded and rebudded with identical kinetics ( Figure S3F ). Therefore, the Cdc14 release endocycle and the G1 endocycle are independent.
Polo kinase Cdc5 is required for Cdc14 release (Visintin et al., 2003) , and Cdc14 endocycles required active Cdc5, even after an initial round of Cdc14 release ( Figure 3D ). The FEAR network and MEN are required for early and late anaphase Cdc14 release respectively (Azzam et al., 2004; Queralt et al., 2006; Stegmeier and Amon, 2004) . The MEN component Cdc15 was required for Cdc14 endocycles, but neither the FEAR network component Spo12, nor the key FEAR pathway event of Net1 phosphorylation by Clb-Cdk, was required ( Figure S3B ,C). Thus, Cdc14 endocycles in Clb2kd-blocked cells may involve mechanisms controlling late-anaphase Cdc14 release in the free-running cell cycle, since both require Cdc5 and Cdc15, but not FEAR pathway components. In bub2D cells, MEN activity is likely near-constitutive (Alexandru et al., 1999; Pereira et al., 2000; Xu et al., 2000) . Cdc14 release endocycles persisted in Clb2kd-arrested bub2D cells ( Figure S3D ), suggesting that these endocycles do not require cyclical inactivation of the SPOC.
Cdc5 is downregulated at the end of mitosis by transcriptional inactivation and by Cdh1-APC-dependent proteolysis (Charles et al., 1998; Shirayama et al., 1998) , and Cdc5 proteolysis promotes Cdc14 resequestration (Visintin et al., 2008) . To determine whether Cdc14 resequestration in endocycles similarly required Cdc5 proteolysis, we tested the Cdh1-resistant Cdc5-DNT mutant (Visintin et al., 2008) . In CDC5-DNT cells deduced to contain > 1X peak Clb2kd, we did not detect multiple Cdc14 release endocycles; 22% of cells showed extended Cdc14 release, and 53% of cells had a short Cdc14 release/resequestration cycle prior to a long release ( Figure 3A ). These very long release periods in CDC5-DNT cells contrasted with the normal duration of Cdc14 release in endocycling CDC5+ cells (see above).
Cdh1 is required for Cdc5 degradation, and cdh1D but not CDH1 cells containing 0.5X to 2X peak Clb2kd released Cdc14 Figure 1B , but cells also cdc5::3XCDC5-DNT. Among cells whose rebudding was delayed for at least 25 min (implying > 1X peak Clb2kd, Figure S1B ), 19/36 cells showed fast Cdc14 release and resequestration, followed by prolonged Cdc14 release. 8/36 showed only prolonged Cdc14 release. (B) As in Figure 1D , but also cdh1D; 30 min Clb2kd-GFP pulse; typical traces for the indicated Clb2kd-GFP ranges. Among cells with > 1X peak Clb2kd-GFP (n = 86), 41% showed a prolonged Cdc14 release period (middle two traces); 43% (cells with highest Clb2kd-GFP) showed release endocycles with a reduced amplitude (bottom trace); Blue bars: anaphase; Red bars: cytokinesis; Green bars: bud emergence. (C) CDC5pr-GFP cells, as in Figure 1B . Trough GFP intensities before rebudding plotted against rebudding times; rebudding delay indicates Clb2kd levels; sample traces below. (D) Cells as in Figure 1D , but also cdc15-2 or cdc5-1; after 35 min to allow initial Cdc14 release at permissive temperature, cells were plated for time-lapse at 37 C (restrictive temperature) (t = 0). for up to 80 min, and did not exhibit Cdc14 endocycles ( Figure 3B) . Surprisingly, however, low-amplitude Cdc14 endocycles occurred in cdh1D cells with > 2X peak Clb2kd ( Figure 3B ). This result suggests a parallel Cdh1-independent pathway allowing Cdc14 endocycles (see Discussion); but the primary mechanism likely requires Cdh1-dependent proteolysis of Cdc5, dependent on the Cdc5 N-terminal destruction box.
Cdc14-Cdh1-Cdc5 Negative Feedback May Contribute to Cdc14 Endocycles Cyclical activation and inactivation of Cdc5 may be obligatory for Cdc14 endocycles, since endocycles are prevented by either constitutively high (CDC5-DNT) or constitutively low Cdc5 (cdc5-1). We hypothesized a negative feedback loop to explain Cdc14 endocycles: Cdc5 promoting Cdc14 release, Cdc14 activating Cdh1 leading to Cdc5 proteolysis, and consequent Cdc14 resequestration. In the wild-type cell cycle, Cdc5 cannot reaccumulate until the next M-phase: CDC5 is co-transcribed with CLB2 under Clb2-dependent positive feedback control (Wittenberg and Reed, 2005) , so Clb2 removal at anaphase blocks further CDC5 transcription. In Clb2kd-blocked cells, persistent Clb2kd could both maintain CDC5 transcription, and inactivate Cdh1 by phosphorylation (in the absence of counterbalancing dephosphorylation by Cdc14), allowing rapid reaccumulation of Cdc5 and endocyclic Cdc14 release and resequestration. This negative feedback hypothesis could explain absence of endocycles in cdc5-1, CDC5-DNT and cdh1D cells.
We used a cell-cycle-regulated CDC5pr-GFP reporter (J. Skotheim, pers. comm.) to measure CDC5 transcription. Consistent with the negative feedback hypothesis, we observed higher trough levels and rapid rebound of CDC5 transcription oscillation in Clb2kd-pulsed cells compared to unpulsed controls (Figure 3C ). Also consistent with the hypothesis, Cdc14 endocycles required new protein synthesis, since endocycles were blocked by addition of cycloheximide after an initial Cdc14 release ( Figure 3D ).
Finally, in cells undergoing Cdc14 endocycles, we observed cyclical accumulation and degradation of Cdc5-GFP fusion protein expressed from the endogenous promoter, out of phase with Cdc14 release ( Figure 3E ; the actual peak of Cdc5-GFP protein is likely to be $15 min. earlier than the observed peak due to the time required for fluorescent maturation of newly synthesized Cdc5-GFP).
A qualitative ODE model ( Figure 3F and Figure S3G ) of a Cdc5-Cdc14-Cdh1 negative feedback loop reproduced our major results, including dependence of Cdc14 endocycle frequency on Clb2kd concentrations ( Figure 2B ).
The experiments above suggest that Cdc14 localization could be controlled by an oscillatory module. Cdc14 release endocycles could come about because Clb2kd accelerates the Cdc14-release-control module, by driving rapid rebound of the Cdc5-Cdc14-Cdh1 negative feedback oscillator ( Figure 2B and Figure 4A ), and blocks Clb-Cdk oscillation, resulting in a temporal separation of the two oscillators.
Elucidating the mechanism of Cdc14 endocycles does not address whether the potential for Cdc14 endocycles is physiologically relevant in the normal cell cycle. To address this issue required additional experimental and analytical studies.
Oscillator Uncoupling Reveals Cdc14 Endocycles in Free-Running Cell Cycles Does the oscillation of this Cdc14 module control timing and execution of normal Cdc14 release in unperturbed cells cycles? Any manipulation trying to study the autonomous behavior of Cdc14-control module will inevitably perturb cell-cycle progression. So, we analyzed this question in two steps: first, we asked whether the Cdc14-control module could oscillate autonomously in free-running cell cycles; second, we studied whether oscillatory behavior of the intact module might be involved in controlling normal Cdc14 release events.
First, we tried to uncouple the Cdc14 module from the ClbCdk oscillator, without blocking the cell cycle. Genetic manipulations providing sufficient uncoupling could allow detection of Cdc14 release endocycles in free-running cell cycles. Plausible coupling components include: 1. CDC5 transcription, activated by Clb-Cdk; 2. Cdh1, activated by Cdc14 and degrading Clbs and Cdc5; 3. the MEN, indirectly activated by mitotic cyclinCdk, since anaphase (promoted by cyclin-Cdk [Fitch et al., 1992] ) activates the MEN ( Figure 4A ).
We made CDC5 transcription independent of Clb-Cdk, using GAL1-URL-CDC5 ( (Visintin et al., 2008) ; the destabilizing URL tag kept Cdc5 at a non-lethal level). Consistent with the oscillatory module hypothesis, in freely cycling GAL1-URL-CDC5 cells, we observed G1-specific Cdc14 endocycles in $70% daughter cells ( Figure 4B ). G1 cells stably contain almost no cyclin-Cdk activity (Mendenhall and Hodge, 1998) , so events directly controlled by a cyclin-Cdk ratchet have no basis for repeated activity in G1 cells.
We did not observe Cdc14 endocycles or Cdc14 release anomalies in cycling cdh1D cells (data not shown), perhaps because Cdh1 contributes to the Cdc14 intrinsic oscillatory mechanism, as well as to its coupling with Cdk oscillations ( Figure 3B ). More complete decoupling could reveal Cdc14 endocycles in the absence of Cdh1, assuming parallel coupled pathways within the Cdc14 oscillatory module (see above). Indeed, additionally deletion of BUB2, eliminating dependence of MEN activation on mitotic cyclin-induced anaphase (Fesquet et al., 1999; Fitch et al., 1992; Pereira et al., 2000) , revealed G1-specific Cdc14 endocycles in cycling cdh1D bub2D cells ( Figure 4B ). BUB2 deletion had little or no effect on its own or in GAL1-URL-CDC5 cells (Figures S4A and S4B ). CDC5-DNT in a CDH1 BUB2 background also induced G1 Cdc14 endocycles ( Figure S4C ).
Daughter preference of endocycles could be due to G1-cyclindependent relocalization of MEN activators such as Lte1 to the incipient bud (Jensen et al., 2002) , sequestering these activators until spindle pole entry into the bud in the next anaphase. Mother cells bud and express G1 cyclins much earlier than daughters (Di Talia et al., 2007) , which could forestall mother G1 Cdc14 endocycles. Actin depolymerization with latrunculin B (LAT-B) prevents Lte1 sequestration by inhibiting budding; LAT-B treatment also inhibits all overt cell-cycle progression (Jensen et al., 2002) . cdh1D bub2D cells incubated with LAT-B exhibited Cdc14 endocycles in unbudded mothers and daughters with equal probability ( Figure 4C ) (up to four endocycles, usually without associated anaphase), supporting the idea that rapid bud emergence and sequestration of MEN activators could prevent Cdc14 endocycles in G1 mother cells.
Therefore, we conclude that the Cdc14-release module can oscillate autonomously in free-running cell cycles. These observations also emphasize the importance of oscillator coupling for maintaining timely, once-per-cell-cycle Cdc14 release in the normal cell cycle.
The Cdc14-Release Module Is Intrinsically Oscillatory at Mid-Cell-Cycle Clb-Cdk Levels The minimal Clb2 level allowing oscillation of the Cdc14 module determines whether this oscillatory behavior could control normal Cdc14 release in unperturbed cell cycles. If this level is low, oscillation of the module will last for most of the cell cycle, implying a likely role in controlling normal Cdc14 release timing and execution.
To determine this critical level, we used LAT-B to inhibit cytokinesis, budding and anaphase, to study the autonomous behavior of the Cdc14 module at low Clb2kd levels. We also deleted BUB2 to avoid the interference of SPOC. BUB2 deletion alone caused no difference in Cdc14 endocycles ( Figure S4A ). In LAT-B-treated bub2 cells, 90 min period Cdc14 release cycles emerged at 0.2X peak Clb2kd-GFP ( Figure 4D ). With < 1X peak Clb2kd, 39/46 cells exhibited Cdc14 endocycles. The frequency-Clb2kd relationship had a similar slope as was obtained in Figure 2B at higher Clb2kd levels ( Figure S5 ). Therefore, the Cdc14-release module oscillates even at Clb2 levels characteristic of early-mid cell cycle, with a frequency very close to normal Cdc14 release cycles ($90 min.), consistent with the oscillator functioning to control Cdc14 release timing in normal cell cycles. The apparently continuous transition from normal Cdc14 release cycles to endocycles also support this conclusion (Figure 2A) .
Control of Cdc14 release by an autonomous oscillator must be compatible with the well-established restriction of Cdc14 release to late mitosis, at the end of the cyclin-Cdk cycle. We show that coupling of the autonomous oscillation of the Cdc14 module to Clb-Cdk is sufficient to yield appropriate regulation and timing of Cdc14 release in the unperturbed cell cycle; this, coupled with the likelihood that the Cdc14 oscillator is functioning during much of the normal cell cycle (see above), makes the Cdc14 oscillator an important candidate for regulating Cdc14 release timing in the normal cell cycle. We extend this concept to oscillatory modules controlling other cell-cycle events.
Cyclin-Cdk Oscillations Could Order Cell-Cycle Events by Phase-Locking
Other cell-cycle events besides Cdc14 release can occur endocyclically, driven by intrinsic oscillating modules without mitotic cyclin-Cdk oscillation. These observations are difficult to fit into Cdk-ratchet models (see Introduction). We considered alternative, non-ratchet-like ways that cyclin-Cdk oscillations could order cell-cycle events. Physiological Clb2kd concentrations linearly controlled Cdc14 release endocycle frequency ( Figure 2B ). Oscillators with different intrinsic frequencies can be synchronized to oscillate at one collective frequency if the frequency of one oscillator is sufficiently controlled by the activity of another, a phenomenon called phase-locking (PL) (Glass, 2001; Winfree, 1967) . A wellknown biological example of PL is the entrainment of the circadian clock to diurnal cycles. Cyclin-Cdk oscillations could similarly entrain or phase-lock Cdc14 release, as well as other autonomous oscillatory modules, promoting orderly and coherent cell-cycle progression ( Figure 5A ).
To demonstrate how PL could order cell-cycle events, we built a conceptual model containing four oscillating modules: the cyclin-Cdk oscillator, and three autonomous ''peripheral'' oscillators controlling specific cell-cycle events (e.g., budding, SPB duplication, Cdc14 release). Without coupling, different intrinsic frequencies of the peripheral oscillators results in a disordered (Kuramoto, 1975 ; Extended Experimental Procedures) with different intrinsic frequencies (indicated) control different cell-cycle events. Assuming a single event is generated as the oscillator's phase evolves passing n*2p or ''12 o'clock.'' Without entrainment by cyclin-Cdk oscillator, each peripheral oscillator evolves uniformly, and there is no fixed order (left) among events they generate. Allowing a cyclin-Cdk oscillator to advance or delay part of the peripheral oscillators' cycles leads to phase-locking and a stable order of events (right). See also Figure S5 .
and irregular sequence of cell-cycle events ( Figure 5B, left) . In simulation, allowing cyclinCdk master oscillator to affect the frequencies of the peripheral ones resulted in all oscillators cycling exactly once per cyclin-Cdk cycle, in a fixed order ( Figure 5B, right) .
This result of a distinct, dynamically stable PL solution for each oscillating module, provided they are coupled to the central Cdk oscillator, is derived from a very simple model, but may be robust to biological complexity in real systems. This is because PL is largely independent of detailed mechanism. Stability is determined by the local dynamical structure near the fixed point (Winfree, 1967) , given sufficiently strong linkage, and reasonably close intrinsic frequencies. These features may be highly evolvable (see Discussion).
Reducing Amplitude of the Cyclin-Cdk Oscillator Results in Disordered Cell-Cycle Events PL models ( Figure 5B ) lead to a key prediction: lowering the amplitude of Clb-Cdk oscillation should weaken entrainment between the Clb cycle and other oscillators and perturb order of PL-controlled cell-cycle events ( Figure 6A ). Cell-cycle control through ratchet-like mechanisms yields entirely different predictions: lowering amplitude should block or delay events, but should not alter event order. In both cases, these considerations are largely independent of model details.
We tried two experimental strategies to lower the amplitude of cyclin-Cdk oscillation. We first used strong constitutive overexpression of the Sic1 inhibitor of Clb-Cdk activity (Mendenhall and Hodge, 1998) . The SIC1 overexpression cassette we used (2X GAL-SIC1) was capable of significantly reducing Clb-Cdk levels in cells previously blocked with approximately peak ClbCdk activity, consistent with the idea that this cassette will similarly lower the peak in cycling cells ( Figure S6A ; Figure 6B ). 2X GAL-SIC1 cells are fully viable. As a contrasting means to lower amplitude, we deleted CDH1 and SIC1, which results in a high trough level of Clb2-Cdk activity but probably little reduction in the peak (Wä sch and Cross, 2002; Yeong et al., 2000) ( Figure 6B ). Although cdh1D sic1D cells are ultimately inviable (Schwab et al., 1997; Visintin et al., 1997) , they undergo multiple cell cycles (Wä sch and Cross, 2002) , allowing analysis of order of events by time-lapse microscopy. Thus, in GAL1-SIC1 cells, Clb-Cdk levels are extremely low during an extended G1, then probably rise to a reduced peak compared to wild-type, while in cdh1D sic1D cells there is probably no period with low ClbCdk levels, but likely a relatively normal peak level.
These two mechanisms for reducing the amplitude do so by opposite means: lowering the peak, versus raising the trough. Ratchet control, in which specific Clb-Cdk levels control sequential steps in a process, predicts very different results from these manipulations, since a ratchet mechanism demands distinct responses to different Clb-Cdk activity levels. In contrast, the PL perspective can predict qualitatively similar outcomes of event disorder in these two cases.
To focus specifically on reduction of amplitude of the ClbCdk oscillation, we deleted the spindle orientation checkpoint component BUB2, to relieve dependence of Cdc14 release on spindle position (Bardin et al., 2000) (Qualitatively similar although lesser effects on budding, cytokinesis, and anaphase Figure 5B , but the amplitude of cyclin-Cdk oscillation is reduced by 15%, resulting in event disorder (compare Figure 5B, right) . (B) 2XGAL1-SIC1 bub2D or cdh1D sic1D bub2D strains may reduce the amplitude of cyclin-Cdk oscillation by lowering the peak Cdk activity or raising the trough (cartoon below). 2XGAL1-SIC1 cells (n = 37) were grown in raffinose medium prior to time-lapse analysis on galactose medium to induce Sic1 (t = 0). cdh1D sic1D GALL-CDC20 cells (n = 35) were imaged on glucose to turn off GALL-CDC20. Cells were classified according to the cell-cycle disorder that appeared first, shown with representative traces (right). Blue bars, nucleolar separation; green bars, budding; red bars, cytokinesis. (C) Cdc14 release and SPB duplication timing in free-running cell cycles predicted by a quantitative phase-locking model. Red: best estimation of parameters; blue: sine wave simulation of ClbCdk cycle. Light-red: solutions with parameters altered ± one standard deviation for one or both of the two parameters (for two combinations no solution could be obtained due to mathematical restrictions of the model; Extended Experimental Procedures). Right panel: phase-locking could entrain SPB duplication oscillator (red) to the correct position early in the Clb-Cdk cycle (blue) (Extended Experimental Procedures). See also Figure S6 .
were observed in a BUB2 background; bub2 deletion alone had no effect [Figure S4A] ).
GAL1-SIC1 expression in bub2D cells resulted in 64% abnormal first cell cycles after Sic1 expression on galactose medium (supernumerary Cdc14 release without nucleolar separation; extra budding without Cdc14 release or cell division; or cytokinesis without Cdc14 release or nucleolar separation [ Figure 6B] ). Remarkably, similar cell-cycle anomalies with close frequencies were also observed in cycling cdh1D sic1D bub2D cells. Those anomalies are not likely due to nonspecific growth defects since GAL1-SIC1 bub2 cells grow well both in bulk culture and when monitored as single cells. cdh1D sic1D occasionally causes preanaphase block, probably due to replication problems (Wä sch and Cross, 2002) ; such cells were excluded from analysis.
The conceptual PL model yielded loss-of-order phenotypes as a result of lowering the amplitude of Cdk oscillation ( Figure 6A ). In contrast, any Cdk-ratchet model would predict that under amplitude changes, the normal orders of cell-cycle events would remain the same, excepting delays or blockages of some events. Further, near-opposite phenotypes would be predicted for lowering the peak versus raising the trough. Thus, the result of out-of-order phenotypes, and the surprising similarity of the phenotypes of two entirely distinct ways of reducing amplitude, support a PL model over a ratchet model. The PL model describes how Cdk oscillation entrains autonomous peripheral oscillators to form a coherent cell cycle, associating once-per-cell-cycle occurrence of an event (e.g., Cdc14 release, SPB duplication) in normal cell cycles with its capacity to undergo endocycles in blocked cells In contrast, in any ratchet model, endocycles must be pathological consequences of cell-cycle blockage. Therefore, an empirical test of the PL versus the ratchet perspectives is to ask whether the response of the oscillatory module to fixed Clb-Cdk levels is consistent with timing in the normal cell cycle. We calculated the stable phase offset (the difference between peak Clb2 and peak Cdc14 release), based on a simple quantitative PL model, containing only three parameters extracted directly from empirical observations on Clb2kd-blocked cells ( Figure 2B ; Extended Experimental Procedures). (For example, one key parameter, strength of coupling of Clb2 to Cdc14 cycle frequency, is measured from the slope of the straight-line fit in Figure 2B .) An analytical solution yielded a phase-offset with Cdc14 release occurring as Clb-Cdk levels decreased (Extended Experimental Procedures; Figure 6C ), consistent with experiment (Stegmeier and Amon, 2004) . Uncertainties in parameter estimation do not significantly affect this conclusion, since increasing or decreasing the parameter estimates by one standard deviation of measurement error, alone or in combination, had little effect ( Figure 6C ). This fit would be unlikely if endocycles are pathological consequences of cell-cycle blockage.
Incorporating the inhibitory effects of Cdc14 release on ClbCdk activity is likely to further stabilize the PL between Cdc14 and Cdk oscillators. We lack sufficient information to determine all parameters in the ''bidirectional'' model, but the same general conclusion is reached (Extended Experimental Procedures).
Any oscillating module whose frequency is controlled by Cdk can potentially be phase-locked. We constructed a similar analytical model for PL of a hypothesized SPB duplication module. Published data are insufficient to obtain empirical estimates of parameters. Still, we could estimate predicted timing using our model and plausible parameter choices (Extended Experimental Procedures). SPB duplication was predicted to occur early in the cell cycle, before the rise in Clb-Cdk, as observed experimentally ( Figure 6C) , showing consistency of timing of SPB duplication with a PL model.
DISCUSSION
Cdc14 Endocycles, Oscillatory Modules, and Phase-Locking The canonical ratchet model for once-per-cell-cycle regulation by cyclin-Cdk oscillations proposes that high and low cyclinCdk levels promote alternating steps of a process. In this case, any fixed level of cyclin-Cdk should result in a terminal arrest with one or the other steps of each cell-cycle process completed and the next never occurring. Cdc14 endocycles at fixed Clb2 levels challenge this idea, as do other autonomous cell-cycle oscillators (see Introduction). The regular oscillation of Cdc14 localization, with frequency controlled by Clb2kd levels, suggests a regulated process rather than noisy or sporadic failure of normal control. As an alternative to ratchet models, to account for existence and entrainment of these endocycles at a common frequency, we propose that the Cdk cycle phaselocks other independent oscillators to order cell-cycle events. Such a PL model is consistent with mechanistic regulatory details that can also support ratchet models; for example, the ability of high mitotic cyclin-Cdk activity to prevent SPB ''licensing'' for duplication is readily interpreted as a mechanism of oscillator coupling. The PL model may provide deeper insight into cell-cycle regulation since it integrates endocycle phenotypes and normal cell-cycle regulation into a coherent framework. Above, we presented experiments supporting PL over ratchet control in the free-running cell cycle, as well as in blocked cells.
Cdc5 proteolysis, controlled by a Cdc14-Cdh1-Cdc5 negative feedback loop, probably contributes to Cdc14 endocycles at high mitotic cyclin levels. Similar conclusions have been reached by others, by different methods (R. Visintin, personal communication). Nevertheless, Cdh1-dependent proteolysis of Cdc5 is not the only mechanism causing Cdc14 resequestration, since resequestration still happened after a delay in the absence of Cdh1; we observed G1 Cdc14 endocycles in bub2D cdh1D cells; and the Cdh1 requirement for endocycles in Clb2kd-blocked cells was lost at very high (>2X peak) Clb2kd levels ( Figure 3B ). The oscillatory Cdc14 module may include parallel mechanisms, ensuring robust oscillation. Interestingly, we found that Mob1-GFP localized to SPB periodically during Cdc14 endocycles in phase with Cdc14 release ( Figure S6B ). Since Mob1's SPB localization may signal MEN activation (Stegmeier and Amon, 2004; Yoshida and Toh-e, 2001 ), MEN activity may oscillate to drive Cdc14 endocycle even in the absence of Cdc14-Cdh1-Cdc5 negative feedback.
The severe disruptions in normal Cdc14 release by manipulations specifically predicted to perturb the autonomous Cdc14 release module, even in free-running cell cycles, imply that oscillatory function of this module is required for normal Cdc14 release timing. A PL control system could transit evolutionarily to a pure ratchet-control system; indeed, this is formally the result of increasing coupling strength to sufficiently high values that the peripheral oscillator will not move within a physiological timescale without a ''kick'' from the entraining oscillator. Different cell-cycle systems, even if initially independently oscillatory, may vary in the degree to which they are at present under ratchet control; for example, DNA replication may be entirely under cyclin-Cdk ratchet control in modern eukaryotes, despite its intrinsically oscillatory character. This may represent a tradeoff between the robustness and simplicity of the PL mechanism, and the cost in some systems of occasional uncoupling (aneuploidy in the case of DNA replication).
Modular Design and Evolution of the Cell Cycle
Modularity may create functional robustness and evolvability (Bhattacharyya et al., 2006; Hartwell et al., 1999) . Our study suggests that some cell-cycle modules are intrinsically oscillatory; coupling of these oscillators to the central Cdk oscillator can nevertheless readily ensure once-per-cell-cycle control ( Figures 5A and 5B) .
The eukaryotic cell cycle evolved from a Cdk-free precursor, since Cdk is a eukaryotic-specific kinase (Nasmyth, 1995) . Further, Cdks may have evolved late, after other eukaryotic cell-cycle-regulatory protein kinases (Krylov et al., 2003) . If processes such as DNA replication and cell division were intrinsically oscillatory before the emergence of Cdk, then Cdk would only need to gain the ability to modulate these oscillators to gradually become a master regulator. This satisfies the evolutionary requirement of utility of intermediate forms (Darwin, 1859) .
We speculate that in primordial eukaryotes, multiple autonomous biochemical oscillators entrained each other to an approximate aggregate rhythm. Cyclin-Cdk oscillation could then have evolved, yielding a stable PL structure. Selection for entrainment in large populations of simulated oscillators selects central pacemaker oscillators (Brede, 2008; Sendina-Nadal et al., 2008) , which provided stability to weakening of oscillator coupling as an unselected ''phenotype''. Further, unevolved random networks of coupled oscillators, constructed computationally in a standard manner (Kuramoto, 1975) , showed increased stability of spontaneous entrainment with increasing centralization of control in network generation ( Figure S6C ).
The predominant model for cell-cycle control involves direct cyclin-Cdk control of cell-cycle events, with surveillance checkpoints to ensure order (Morgan, 2007 ). An earlier model (Morgan, 2007; Pringle and Hartwell, 1981) , considered cellcycle control to be due to parallel, interlocking but unidirectional morphogenetic pathways arranged in a functional sequence map. Our PL model combines aspects of both: a central cyclin-Cdk oscillator phase-locks independent oscillatory modules controlling specific cell-cycle events. Such independent cyclical processes are analogous to ''independent functional sequences'' in the cdc formulation -processes that can operate freely in parallel, such as DNA replication and spindle morphogenesis (Hartwell, 1974) . Phase-locking of these autonomous oscillators by a central Cdk pacemaker could have been important in early cell-cycle evolution, and this mechanism may control multiple autonomous cell-cycle oscillators, even in modern eukaryotes.
EXPERIMENTAL PROCEDURES
Time-Lapse Microscopy
Pulsed expression and release of GAL1-CLB2kd(-GFP) in MET3-CDC20 blocked cells and time-lapse microscopy were previously described (Bean et al., 2006) .
Image Analysis
Image segmentation and quantification were described (Bean et al., 2006; Charvin et al., 2008) . Cdc14 release was quantified as the coefficient of variation (CV, standard deviation divided by mean) of Cdc14-YFP pixel intensities (mother and bud treated separately), divided by the Net1-mCherry CV. A narrow band-width GFP filter (Chroma, 41020) and the contribution of pure GFP to the YFP channel allows computational recovery of pure YFP signal. The small amount of bud-neck-localized Cdc14 was excluded from quantification. Smoothing of time-lapse series was by 3-neighbor averaging method.
Model Calculations and Computer Simulations
Basic forms of the ODE model in Figure 3F and parameters are adopted from Chen's 2004 cell-cycle model. Simulation is performed using MATLAB, as is in Figure 5B . Simulation of Kuramoto oscillator population in Fig.S6C was programmed in C language with Numerical Recipe 2.0 package.
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